Nathaniel Finlay Dillonsmith

Nathaniel Dillonsmith practices exclusively in the area of intellectual property law, focusing on pharmaceutical patent litigation and proceedings under the Patented Medicines (Notice of Compliance) Regulations . Nathaniel completed his J.D. and Bachelor of Engineering Science in Integrated Engineering at the University of Western Ontario. Nathaniel was called to the Ontario Bar in 2014 and practiced at a prominent litigation boutique in downtown Toronto for several years before joining Sprigings Intellectual Property Law in March of 2018.

Application under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations regarding apalutamide.

Application under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations regarding apixaban.

Action under section 8.2 of the Patented Medicines (Notice of Compliance) Regulations regarding apalutamide.

Actions under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,632,375 (diclofenac).

Actions under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,932,603 (diclofenac).